Skip to main content

Cardiovascular Drugs and Therapy OnlineFirst articles

04.02.2023 | Original Article

Sitagliptin Ameliorates Creb5/lncRNA ENSMUST00000213271-Mediated Vascular Endothelial Dysfunction in Obese Mice

Obesity, a global public health issue, is considered an independent risk factor in the development of metabolic and cardiovascular diseases [ 1 ]. A chronic inflammatory state in obesity causes the disruption of vascular homeostasis and contributes …

Open Access 27.01.2023 | Original Article

The Influence of the FFAR4 Agonist TUG-891 on Liver Steatosis in ApoE-Knockout Mice

Nonalcoholic fatty liver disease (NAFLD), characterized by excessive accumulation of triglycerides in hepatocytes, is the most common chronic liver disorder in the western world, and its prevalence is rapidly increasing globally [ 1 , 2 ]. NAFLD …

25.01.2023 | Short Communication

Impact of Heart Failure History at Baseline on Cardiovascular Effects of GLP-1 Receptor Agonists in Type 2 Diabetes: a Meta-analysis

Heart failure (HF) is prevalent in up to 22% of people with type 2 diabetes mellitus (T2DM) [ 1 ]. The increased risk of incident HF in T2DM has been found to persist even after adjusting for age, hypertension, hypercholesterolemia, and coronary …

Open Access 24.01.2023 | Original Article

Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke

Atrial fibrillation (AF) is associated with a five-fold higher risk of ischaemic stroke, and a higher risk of stroke recurrence and mortality [ 1 ]. The recommended management of AF after ischaemic stroke is to offer oral anticoagulants (OACs) to …

20.01.2023 | Original Article

Bicyclol Alleviates Streptozotocin-induced Diabetic Cardiomyopathy By Inhibiting Chronic Inflammation And Oxidative Stress

In recent decades, the prevalence of diabetes has been increasing, leading to higher medical expenses for patients with diabetes and a decline in quality of life [ 1 ]. Diabetic cardiomyopathy (DCM) is a significant cause of morbidity and mortality …

Über diese Zeitschrift

Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field.

Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focusses on developments in atherosclerosis, hyperlipidemia, diabetes, ischemic syndromes and arrhythmias. The Journal is an authoritative source of current and relevant information that is indispensable for basic and clinical investigators aiming for novel, breakthrough research as well as for cardiologists seeking to best serve their patients.

Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Web of Science and PubMed/Medline among other abstracting and indexing services. The regular articles and frequent special topical issues equip you with an up-to-date source defined by the need for accurate information on an ever-evolving field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of new products and therapies which furnishes you with the details on cardiovascular pharmacology that you will refer to time and time again.

Five Reasons to Publish Your Article in Cardiovascular Drugs and Therapy:

· High usage: Articles frequently downloaded from month to month

· Wide distribution: Institutions worldwide having full text access

· Efficient handling: 18 days between submission and first decision

· Fast publication: 17 days between acceptance and online publication

· International readership: North America, Asia, Europe, Middle East and South America

Cardiovascular Drugs and Therapy
Volume 10/1997 - Volume 37/2023
Springer US
Elektronische ISSN
Print ISSN


Bestellen Sie unseren kostenlosen Newsletter Update Kardiologie und bleiben Sie gut informiert – ganz bequem per eMail.